Central Licensing Authority

New Rules for Clinical Trials and Drugs Promote Research and Ensure Patient Safety

Posted by: DigiVigyan May 30, 2019

Ministry of Health and Family Welfare of India not

7
0
30th May, 2019

Draft of New Regulations for Clinical Trials in India Favours Drug Development in the Country

Posted by: DigiVigyan May 9, 2019

The Ministry of Health and Family Welfar

7
0
9th May, 2019

What's New ?

Regulation/Guidelines

Notification For Ultrasound Equipment From CDSCO: Extension Of Timeline

The Ministry of Health and Family Welfare has recently come up with a release of notification dated 21st October 2020 to extend the timeline from 1st day of November, 2020”...

5th January, 2021

Regulation/Guidelines

CDSCO releases the timeline for Regularization of Rational Fixed Dose Combination in India

Indian pharma market is flooded with irrational Fixed Dose Combination (FDCs) and is an important topic for critical and scientific analysis. The country needs some regulatory laws for FDCs after...

3rd December, 2020

Regulation/Guidelines

New Classifications Of Non-Notified Medical Devices And IVDs In India By CDSCO

The Central Drugs Standard Control Organisation (CDSCO) has released two notices on September 3, 2020, including the classification of non-notified medical devices and in-vitro diagnostic devices (IVDs). To simplify the...

9th November, 2020

Regulation/Guidelines

CDSCO Releases Draft Regulatory Guidelines For The Development Of Vaccines In COVID-19 Pandemic

Coronavirus still poses a potential threat to the global population, but no vaccines protect the body against the virus, causing COVID-19. The coronavirus spreads quickly, and majority of the world's...

26th October, 2020